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2015 Surveillance of group B streptococcus (GBS) strains
isolated from invasive diseases among adults in Belgium: 
Bacteriological and clinical characteristics.
OBJECTIVES 
Clinical manifestations 
Even if GBS disease risk is highest during the first
trimester of life, GBS is also an important cause of
invasive infection in adults, especially the elderly,
the immunocompromised or patients with chronic
illnesses.
To provide an overview of bacteriological and
clinical characteristics of GBS causing invasive
diseases in non-pregnant adult in Belgium.
1. To describe the main reported clinical
manifestations and suspected focus.
2. To characterize relevant epidemiological
markers of the isolated GBS strains.
• Determination of their capsular-
polysaccharide (CPS) types and distribution.
• Determination of their pili types and
distribution.
• Determination and description of their
antimicrobial susceptibility profile.
• Determination and distribution of macrolide




§ In	Belgium,	bacteremia without identified focus	and	skin-soft	tissue	infections	were the	main	clinical manifestations	of	GBS	causing
invasive	infection	among non-pregnant adults.
§ Bacteriological characteristics of	GBS	isolated from adults with invasive	disease were consistent	with reported data	among European
countries;	CPS	types	Ia,	II	and	V	accounting 67.7%.	
§ Macrolides/lincosamides resistance rate	(35.7%)	has	slightly increased during the	last	decade and	is mainly associated to	CPS	type	V	and	
to	ermB determinants.			


















• Multiplex	PCR	for	ErmB,	ErmTr,	MefA and	LSaC genes	
Population:
• Overall during the year 2015, on a voluntary base, laboratories
belonging to the national surveillance network sent to the NRC
a total of 143 GBS strains isolated from invasive disease among
non-pregnant adults.










Distribution of CPS types and pili types
• The most prevalent CPS types were types Ia (25.1%), V (23%) and III (19.6%), accounting together
for 67.7%. CPS types II (9.8%), IV (9.8%), Ib (7%), VI (1.4%), VII (1.4%), VIII (1.4%) and IX (0.7%) represented the
remaining cases. One strain remained non typeable. See Figure 1.
• Every isolate of GBS harboured at least one pili gene or a combination of genes. The pili PI1+ PI2a
association was far predominant as detected in 50.5% of isolates. . See Figure 2.
• Pili gene were not evenly distributed among strains with different CPS types. Among GBS with
CPS type Ia, the pili type PI2a was highly the most prevalent and represented a characteristic of CPS type Ia as
rarely detected alone among other CPS types. The combination PI1+PI2a was the most prevalent among CPS
types V, Ib, II,and IV. Both combinations PI1+PI2a and PI1+PI2b were the major combinations of pili genes
detected among CPS type III. PI2b gene alone was only detected in one CPS Type III strain. See Figure 1.
Table: Clinical diagnoses for non-pregnant adults with invasive GBS infection.
§ Susceptibility to beta-lactams
• All isolates were fully S to penicillin with MICs ranging from 0.03 to 0.125 mg/L.
• According to Kimura’s procedure and interpretative criteria, no decreased susceptibility
to beta-lactams was detected.
§ Susceptibility to macrolide-lincosamide
• Out of 143 isolates, 51 (35.7%) were resistant to erythromycin and/or clindamycin.
Rate of resistance was not evenly distributed among GBS of different CPS types. See
Figure 3.
• As shown in Figure 4 the major phenotype of resistance was cMLS (60.6% of resistant
isolates), the constitutive resistant phenotype. The inducible, iMLS, phenotype was
demonstrated among 17.8% of the resistant GBS; 19.6% of GBS showed isolated
resistance to erythromycin (M phenotype) and the L phenotype, isolated resistance to
clindamycin) was detected for one isolate.
• The distribution of the genes coding for resistance, ErmB, ErmTr, MefA and LsaC
harboured by these 51 isolates is shown in Figure 5.
Figure 5: Distribution of the resistance genes to 
macrolide-lincosamide harboured by the 51 GBS 
isolates expressing resistance
Figure 4: Distribution of resistance phenotypes to 
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§ Bacteremia without focus	(or	not	reported)



















Figure 2: Distribution of the pili genotypes of 143 
GBS strains isolated from adults with invasive 
disease.
Figure 1: Distribution of CPS types of 143 GBS strains 
isolated from adults with invasive disease, and 
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Rate	(%)	of	resistance Figure 3: Rate (%) of 
resistance to 
macrolide/lincosamide among 
the different CPS types of GBS 
isolated from non-pregnant 
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